|Five Named to NIAID Advisory Council|
The five newly appointed members to the National Advisory Allergy
and Infectious Diseases Council were recently announced. The council
is the principal advisory body for the National Institute of Allergy
and Infectious Diseases (NIAID).
The council provides recommendations on the conduct and support
of research, including training young scientists and disseminating
health information derived from NIAID research. It embodies a diverse
perspective on science, health and the human impact of disease.
The council is composed of physicians, scientists and representatives
of the public who contribute their time and expertise for a four-year
The new council members are Ann Arvin, M.D., of Stanford University
School of Medicine; Carol Carter, Ph.D., of the State University
of New York at Stony Brook; Louis Picker, M.D., of Oregon Health
and Science University; Regina Rabinovich, M.D., M.P.H., of the
Global Health Program at the Bill and Melinda Gates Foundation;
and Christel Uittenbogaart, M.D., of the University of California,
Ann Arvin, M.D., is Lucile Salter Packard Professor of Pediatrics
and professor of microbiology and immunology at Stanford University
School of Medicine. She also serves as vice provost and dean of
research at Stanford University. Her principal research interests
are the human herpes viruses and childhood viral diseases and vaccines.
Dr. Arvin conducted early studies of a varicella-zoster virus vaccine
that is now licensed for the prevention of chickenpox and zoster.
She has served on many national committees, including the Advisory
Committee to the NIAID Collaborative Antiviral Study Group and
the National Vaccine Advisory Committee to the Secretary of HHS.
Carol Carter, Ph.D., is professor of molecular genetics and microbiology
and adjunct professor of physiology and biophysics at the State
University of New York at Stony Brook. She serves as co-chair of
graduate admissions for the Stony Brook Program in Molecular Genetics
and Microbiology and as director of the summer research internship
program for undergraduates. Dr. Carter's major research interest
is replication of HIV with a focus on viral assembly and trafficking
events required for virus release from infected cells. She is a
member of the NIH Etiology and Pathogenesis Planning Committee.
Louis Picker, M.D., is associate director of the Vaccine and Gene
Therapy Institute and professor of pathology, molecular microbiology,
and immunology at Oregon Health and Science University. He is also
the director of the Pathobiology and Immunology Division of the
Oregon National Primate Research Center. Dr. Picker's laboratory
focuses on delineating the physiology of T-cell memory in primates,
mechanisms of protection against persistent pathogens, AIDS vaccine
development, and the immunopathogenesis of AIDS-causing lentiviruses.
Regina Rabinovich, M.D., M.P.H., is director of the infectious
diseases component of the Global Health Program at the Bill & Melinda
Gates Foundation. She directs the development and implementation
of drug and vaccine strategies to prevent, treat and control diseases
relevant to global health, such as malaria, pneumonia, diarrhea
and human papillomavirus (HPV). Dr. Rabinovich is on the board
of several organizations involved in global health and infectious
diseases, including the National Center for Infectious Diseases
at CDC, African Malaria Network Trust and the Institute for OneWorld
Christel Uittenbogaart, M.D., is professor of pediatrics and microbiology,
immunology and molecular genetics at the University of California,
Los Angeles. Her research focuses on the impact of HIV on the developing
immune system and the role of immune activation in HIV pathogenesis.
She has served on NIH grant review committees and is also the executive
director of the Midwinter Conference of Immunologists, an annual
conference that communicates the most recent developments in the
field of immunology.
NIAID is a component of the National Institutes of Health. NIAID
supports basic and applied research to prevent, diagnose and treat
infectious diseases such as HIV/AIDS and other sexually transmitted
infections, influenza, tuberculosis, malaria and illness from potential
agents of bioterrorism. NIAID also supports research on basic immunology,
transplantation and immune-related disorders, including autoimmune
diseases, asthma and allergies.
News releases, fact sheets and other NIAID-related materials are
available on the NIAID Web site at http://www.niaid.nih.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.